Pediatric Antibiotic Reconstitution and Dilution Guidelines
The provided evidence does not contain specific reconstitution and dilution guidelines from Nelson's Textbook of Pediatrics, but rather presents comprehensive dosing recommendations from IDSA guidelines that can guide antibiotic preparation in pediatric practice.
Key Dosing Information by Antibiotic Class
Beta-Lactam Antibiotics
Ampicillin:
- Neonates ≤7 days and ≤2000g: 50 mg/kg/day divided every 12 hours 1
- Neonates ≤7 days and >2000g: 75 mg/kg/day divided every 8 hours 1
- Neonates >7 days and >2000g: 100 mg/kg/day divided every 6 hours 1
- Infants and children: 100-200 mg/kg/day divided every 6 hours 1
- For severe pneumococcal infections: 150-200 mg/kg/day every 6 hours 1
- For resistant pneumococcus (MIC ≥4.0): 300-400 mg/kg/day every 6 hours 1
Ampicillin-Sulbactam:
- Infants: 100-150 mg ampicillin/kg/day divided every 6 hours 1
- Children: 100-200 mg ampicillin/kg/day divided every 6 hours 1
Ceftriaxone:
- Neonates ≤7 days: 50 mg/kg/day given every 24 hours 1
- Neonates >7 days and >2000g: 50-75 mg/kg/day given every 24 hours 1
- Infants and children: 50-75 mg/kg/day divided every 12-24 hours 1
- For resistant pneumococcus: 100 mg/kg/day every 12-24 hours 1
- Critical caveat: Should not be used in hyperbilirubinemic neonates 1
Cefotaxime:
- Children >1 month: 150 mg/kg/day every 8 hours 1
Ceftazidime:
- Neonates <1200g: 100 mg/kg/day divided every 12 hours 1
- Neonates >2000g: 100-150 mg/kg/day divided every 8-12 hours 1
- Infants and children ≤12 years: 100-150 mg/kg/day divided every 8 hours 1
Cefepime:
- Neonates ≤14 days: 30 mg/kg every 12 hours 1
- Infants >14 days and children ≤40 kg: 50 mg/kg every 12 hours 1
- Important gap: No recommendation available for infants 2 weeks to 2 months of age 1
Cefazolin:
- Children >1 month: 75 mg/kg every 8 hours 1
- For methicillin-susceptible S. aureus: 150 mg/kg/day every 8 hours 1
Aminoglycosides
Gentamicin:
- Premature neonates <1000g: 3.5 mg/kg every 24 hours 1
- Neonates 0-4 weeks and <1200g: 2.5 mg/kg every 18-24 hours 1
- Neonates ≤7 days: 2.5 mg/kg every 12 hours 1
- Neonates >7 days and >2000g: 2.5 mg/kg every 8 hours 1
- Term neonates with normal renal function (once daily): 3.5-5 mg/kg every 24 hours 1
- Infants and children <5 years: 2.5 mg/kg every 8 hours 1
- Children ≥5 years: 2-2.5 mg/kg every 8 hours 1
- Once daily dosing (normal renal function): 5-7.5 mg/kg every 24 hours 1
- Special populations: Some patients (cystic fibrosis, burns, febrile neutropenia) may require larger or more frequent doses 1
Amikacin:
- Neonates 0-4 weeks and <1200g: 7.5 mg/kg every 18-24 hours 1
- Neonates ≤7 days and >2000g: 7.5-10 mg/kg every 12 hours 1
- Neonates >7 days and >2000g: 10 mg/kg every 8 hours 1
- Infants and children: 15-22.5 mg/kg/day divided every 8 hours 1
- Special populations: Initial doses of 30 mg/kg/day divided every 8 hours may be needed in cystic fibrosis or febrile neutropenic patients 1
Glycopeptides and Oxazolidinones
Vancomycin:
- Standard dosing: 40-60 mg/kg/day divided every 6-8 hours 1
- For MRSA: Dosing to achieve an AUC/MIC ratio >400 1
Linezolid:
- Neonates <7 days and birthweight <1200g: 10 mg/kg every 8-12 hours (use every 12 hours if <34 weeks gestation) 1
- Children <12 years: 30 mg/kg/day every 8 hours 1
- Children ≥12 years: 20 mg/kg/day every 12 hours 1
Fluoroquinolones
Ciprofloxacin:
- Neonates: 7-40 mg/kg/day divided every 12 hours 1
- Infants and children: 20-30 mg/kg/day divided every 12 hours 1
- Critical caveat: Experience in neonates is limited; risks and benefits must be assessed prior to use 1
Levofloxacin:
- Children 6 months to 5 years: 10 mg/kg every 12 hours (maximum 500 mg) 1
- Children ≥5 years: 10 mg/kg every 24 hours (maximum 500 mg) 1
- For resistant pneumococcus: 16-20 mg/kg/day in 2 doses for children 6 months to 5 years; 8-10 mg/kg/day once daily for children 5-16 years (maximum 750 mg) 1
Carbapenems
Imipenem-Cilastatin:
- Neonates 0-4 weeks and <1200g: 20 mg/kg every 18-24 hours 1
- Neonates ≤7 days and 1200-1500g: 40 mg/kg/day divided every 12 hours 1
- Neonates ≤7 days and >1500g: 50 mg/kg/day divided every 12 hours 1
- Neonates >7 days and >1500g: 75 mg/kg/day divided every 8 hours 1
- Infants <3 months: 100 mg/kg/day divided every 6 hours 1
- Infants ≥3 months and children: 60-100 mg/kg/day divided every 6 hours 1
Antifungals
Fluconazole:
- Neonates, infants, and children: 12 mg/kg/day once daily 1
Caspofungin:
- Children 2-11 years: Loading dose of 70 mg/m²/day on day 1, followed by 50 mg/m²/day thereafter 1
- Children ≥12 years: Loading dose of 70 mg on day 1, followed by 50 mg once daily thereafter 1
Anidulafungin:
- Children 2-17 years: 1.5 mg/kg/day (maximum 100 mg) 1
- Important caveat: Experience in children is limited 1
Critical Practical Considerations
Weight-Based Dosing Challenges
- In resource-limited settings where calibrated scales are unavailable, alternative methods may be necessary 1
- The Broselow Tape can estimate bodyweight based on body length, though accuracy varies by geographical population 1
- The Mercy TAPE uses mid-upper arm circumference and humeral length as surrogate measures 1
Reconstitution Best Practices
- 75.5% of mothers use boiled then cooled water for reconstitution 2
- 48.4% use a syringe to measure water accurately 2
- 76.6% add water in two steps as recommended 2
- 98.0% shake the suspension bottle before use 2
Administration Accuracy
- Syringes are considered the most accurate tool for dose administration (78.2% preference) 2
- Pharmacists should supply syringes with suitable calibration for dose administration 2
Storage Requirements
- Dry powder antibiotics: 44.2% store in medicinal cabinet 2
- Reconstituted suspensions: 56.5% store in refrigerator 2
- Pharmacists must counsel parents about appropriate storage conditions specific to each antibiotic 2
Common Pitfalls to Avoid
- Neonatal dosing errors: Always account for both postnatal age AND birthweight when dosing neonates 1
- Ceftriaxone in jaundiced neonates: Absolute contraindication in hyperbilirubinemic neonates due to displacement of bilirubin from albumin 1
- Fluoroquinolone use in children: Limited experience and potential for cartilage toxicity requires careful risk-benefit assessment 1
- Aminoglycoside monitoring: Patients with cystic fibrosis, burns, or febrile neutropenia may require higher doses with therapeutic drug monitoring 1
- Once-daily aminoglycoside dosing: Only appropriate in patients with normal renal function 1